Symbols / INBX Stock $129.06 +7.61% Inhibrx Biosciences, Inc.

Healthcare • Biotechnology • United States • NMS
INBX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Mark Paul Lappe
Exch · Country NMS · United States
Market Cap 1.89B
Enterprise Value 1.87B
Income -140.06M
Sales 1.30M
FCF (ttm) -84.46M
Book/sh 0.55
Cash/sh 8.50
Employees 109
Insider 10d —
IPO May 29, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -46.26
PEG —
P/S 1,450.17
P/B 235.51
P/C —
EV/EBITDA -14.09
EV/Sales 1,436.90
Quick Ratio 3.68
Current Ratio 3.93
Debt/Eq 1,338.82
LT Debt/Eq —
EPS (ttm) -9.04
EPS next Y -2.79
EPS Growth —
Revenue Growth -100.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-13
Earnings (prior) 2026-03-19
ROA -51.58%
ROE -197.85%
ROIC —
Gross Margin 0.00%
Oper. Margin -103.87%
Profit Margin 0.00%
Shs Outstand 14.61M
Shs Float 7.81M
Insider Own 23.26%
Instit Own 81.74%
Short Float 19.58%
Short Ratio 8.56
Short Interest 2.14M
52W High 155.29
vs 52W High -16.89%
52W Low 10.84
vs 52W Low 1,090.59%
Beta —
Impl. Vol. 1.41%
Rel Volume 2.19
Avg Volume 281.77K
Volume 617.20K
Target (mean) $300.00
Tgt Median $300.00
Tgt Low $300.00
Tgt High $300.00
# Analysts 1
Recom Buy
Prev Close $119.93
Price $129.06
Change 7.61%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-104.07
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest INBX news

No recent news from Yahoo. Try the RSS feed for latest INBX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-07 VIKING GLOBAL INVESTORS LP Beneficial Owner of more than 10% of a Class of Security — 350,000 $32.25 $11,287,500
2025-03-27 KAYYEM JON FAIZ Director — 90,000 $0.00 $0
2024-12-16 KAYYEM JON FAIZ Director — 500,000 $0.00 $0
2024-12-06 KAYYEM JON FAIZ Director — 52,000 $0.00 $0
2024-11-20 KAYYEM JON FAIZ Director — 107,186 $14.19 $1,523,620
2024-10-03 VUORI KRISTIINA S. Director — 6,667 $15.00 $100,005
2024-09-16 LAPPE MARK Chief Executive Officer — 40,000 $15.05 $629,117
2024-09-11 VUORI KRISTIINA S. Director — 6,636 $15.00 $99,992
2024-09-10 LAPPE MARK Chief Executive Officer — 44,000 $15.19 $671,150
2024-09-03 LAPPE MARK Chief Executive Officer — 40,000 $14.02 $596,763
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category